Of these ten, six hub genes (CTSG, MMP9, PRTN3, RETN, RNASE2 and RNASE3) may be used as CML diagnostic markers. This evidence concerns the gene CTSG and chronic myelogenous leukemia, BCR-ABL1 positive.